Amyris Inc
F:3A01
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Amyris Inc
Long-Term Investments
Amyris Inc
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Amyris Inc
F:3A01
|
Long-Term Investments
$3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Long-Term Investments
$432m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PPG Industries Inc
NYSE:PPG
|
Long-Term Investments
$332m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
Albemarle Corp
NYSE:ALB
|
Long-Term Investments
$900.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Amyris Inc
Glance View
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.
See Also
What is Amyris Inc's Long-Term Investments?
Long-Term Investments
3m
USD
Based on the financial report for Dec 31, 2022, Amyris Inc's Long-Term Investments amounts to 3m USD.
What is Amyris Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-14%
Over the last year, the Long-Term Investments growth was -68%. The average annual Long-Term Investments growth rates for Amyris Inc have been -14% over the past three years .
